DelveInsight Business Research LLP

DelveInsight has launched a new report on “Chronic Kidney Disease – Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Chronic Kidney Disease – Market Insights, Epidemiology, and Market Forecast-2030″report delivers an in-depth understanding of the Chronic Kidney Disease, historical and forecasted epidemiology as well as the Chronic Kidney Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

1. The total prevalent population of Chronic Kidney Disease in the 7MM was 65,988,842 in 2017, during the study period [2017–2030]. Estimates show the highest prevalent population of Chronic Kidney Disease is in the United States, with 37,809,570 cases in 2017.

2. The second most prevalent cases of Chronic Kidney Disease in 7MM were recorded in Japan with 13,758,938 cases in 2017.

3. The findings suggest that the overall prevalence of CKD increased from 12% to 14% between 1988 and 1994 and from 1999 to 2004, but has remained relatively stable since 2004. 

Key benefits of the report:

1. Chronic Kidney Disease  market report covers a descriptive overview and comprehensive insight of the Chronic Kidney Disease  epidemiology and Chronic Kidney Disease  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. The Chronic Kidney Disease market report provides insights on the current and emerging therapies.

3. Chronic Kidney Disease market report provides a global historical and forecasted market covering drug outreach in 7MM.

4. The Chronic Kidney Disease market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Chronic Kidney Disease market.

Got queries? Click here to know more about Chronic Kidney Disease Market Landscape.

Chronic Kidney Disease Overview

Chronic kidney disease (CKD) means your kidneys are damaged and can’t filter blood the way they should. The disease is called “chronic” because the damage to your kidneys happens slowly over a long period of time. This damage can cause wastes to build up in your body.

The key players involved in the Chronic Kidney Disease market:

• GlaxoSmithKline, 

• Akebia Therapeutics, 

• FibroGen/ Astellas Pharma/ AstraZeneca, 

• Boehringer Ingelheim, 

• Astra Zeneca, 

• Tricida, 

• Reata Pharmaceuticals, 

• Corvidia Therapeutics

• And others

The launch of the emerging therapies is expected to significantly impact the Chronic Kidney Disease treatment scenario in the upcoming years:-

Drug covered

• Daprodustat, 

• Vadadustatm, 

• Roxadustat, 

• Empagliflozin, 

• Dapagliflozin, 

• Veverimer, 

• Bardoxolone Methyl, 

• Ziltivekimab, 

• And others.

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Chronic Kidney Disease  Patient Share (%) Overview at a Glance

5. Chronic Kidney Disease  Market Overview at a Glance

6. Chronic Kidney Disease  Disease Background and Overview

7. Chronic Kidney Disease  Epidemiology and Patient Population

8. Country-Specific Patient Population of Chronic Kidney Disease 

9. Chronic Kidney Disease  Current Treatment and Medical Practices

10. Unmet Needs

11. Chronic Kidney Disease  Emerging Therapies

12. Chronic Kidney Disease  Market Outlook

13. Country-Wise Chronic Kidney Disease  Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Chronic Kidney Disease  Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Chronic Kidney Disease Pipeline 

“Chronic Kidney Disease Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the  Chronic Kidney Disease market. A detailed picture of the  Chronic Kidney Disease pipeline landscape is provided, which includes the disease overview and  Chronic Kidney Disease treatment guidelines.

Chronic Kidney Disease Epidemiology

DelveInsight’s ‘Chronic Kidney Disease  Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Chronic Kidney Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/